Simulations Plus, Inc.

NASDAQ:SLP

Medical - Healthcare Information Services

Healthcare
$18.50 +0.11%

+$0.02 today

Market cap
$374.16M
Beta
1.32
P/E (TTM)
-5.9
EPS (TTM)
-$3.12
52W Low $11.09High $21.01

Volume 0.00M

Average 0.35M

SLP Interest Income

Income earned on cash, deposits, and investments held by the company.

Simulations Plus, Inc.NASDAQ: SLP

Interest Income · Q2 FY2026 · quarter ended Feb 2026

Interest income growth accelerates

Q2 FY2026 interest income of $288K rose 87.0% year over year, ahead of the -52.9% change in trailing-twelve-month interest income. Sequentially, it rose 7.9% from the prior quarter. Over 3 fiscal years it compounded at +0.2% a year.

Context

  • Interest income amounted to 0.9% of revenue in FY2025, down 5.3 pp from a year earlier.
  • Interest income increased in 2 of the last 3 fiscal years.

What to watch

Whether quarterly growth of +87.0% holds above the trailing-twelve-month pace of -52.9%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterFeb 2026
$288K+7.9% QoQ
Last fiscal yearAug 2025
$722K-83.5% YoY
LTMFeb 2026
$964K-52.9% YoY
Interest Income past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+87.0%——
1 year-83.5%——
3-year CAGR+0.2%——
5-year CAGR——
10-year CAGR——

Interest Income history

USD · from the income statement

Latest · FY2025
722K USD
Year-over-year change
-83.5%
4-year CAGR
+37.7%

Interest Income vs competitors

How SLP compares with its peers on the latest reported figures

  • Peers report in different currencies, so interest income is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of -52.9% is the 7th highest of 8, against a peer median of -30.9%.
  • Interest income amounts to 1.2% of revenue for SLP, versus a peer median of 0.3%.
SLP Competitors
Interest Income for SLP and competitors
Company Period LTM YoY 3-year CAGR% of revenue
CLLSCellectis S.A.LTM Mar 2026$8.47M USD-30.9%+103.9%12.4%
ANROAlto Neuroscience, Inc.LTM Mar 2026$6.34M USD-30.5%+286.9%—
DHDefinitive Healthcare Corp.LTM Mar 2026$6.2M USD-51.3%+35.6%2.6%
SOPHSOPHiA GENETICS S.A.LTM Mar 2026$1.71M USD-51.9%+12.2%2.1%
ACIUAC Immune S.A.LTM Mar 2026CHF 1.36M CHF-58.3%+200.1%36.6%
SLPSimulations Plus, Inc.LTM Feb 2026$964K USD-52.9%+0.2%1.2%
OPRXOptimizeRx CorporationLTM Mar 2026$342K USD-14.3%-25.5%0.3%
NRCNational Research CorporationLTM Mar 2026$127K USD+27.0%-12.9%0.1%
AGLAgilon Health, Inc.LTM Mar 2026$0 USD——0.0%
NAKANakamoto Inc.LTM Mar 2026$0 USD——0.0%
KRROKorro Bio, Inc.LTM Mar 2026$0 USD——0.0%
Peer median (excluding SLP) —-30.9%+35.6%0.3%

Competitors are the stored peer set for SLP. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Aug 2021
FY2022
Aug 2022
FY2023
Aug 2023
FY2024
Aug 2024
FY2025
Aug 2025
Revenue46.47M53.91M59.58M70.01M79.18M
Cost of Revenue10.6M10.82M11.63M26.86M32.96M
Gross Profit35.87M43.08M47.95M43.15M46.22M
Gross Margin77.2%79.9%80.5%61.6%58.4%
Research & Development4.05M3.21M4.5M5.75M6.88M
Selling, General & Admin20.57M24.97M34.72M31.27M32.85M
Operating Expenses24.61M28.17M39.22M37.02M116.95M
Depreciation & Amortization3.59M3.57M3.84M5.67M8.21M
EBITDA14.7M18.69M13.07M18.08M14.7M
EBITDA Margin31.6%34.7%21.9%25.8%18.6%
Operating Income11.25M14.91M8.73M6.13M(70.73M)
Operating Margin24.2%27.7%14.6%8.8%-89.3%
Interest Income201K717K4.13M4.38M722K
Interest Expense22K0000
Other Income / Expenses(168K)204K2.97M6.28M1.35M
Income Before Tax11.09M15.12M11.7M12.41M(69.38M)
Pre-Tax Margin23.9%28.0%19.6%17.7%-87.6%
Income Tax Expense1.3M2.63M1.73M2.46M(4.66M)
Net Income9.78M12.48M9.96M9.95M(64.72M)
Net Margin21.1%23.2%16.7%14.2%-81.7%
EPS (Basic)0.490.620.500.50(3.22)
EPS (Diluted)0.470.600.490.49(3.22)
Weighted Avg Shares20.05M20.2M20.08M19.99M20.1M
Weighted Avg Shares (Diluted)20.74M20.75M20.47M20.3M20.1M

Simulations Plus, Inc.

NASDAQ:SLP

Intrinsic Alpha fair value

Locked

Current Price

$18.50

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.